New drug safety check: how does JP-1366 mix with heart meds?
NCT ID NCT07265466
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is checking if a new drug called JP-1366 is safe when taken with common heart medications like clopidogrel, aspirin, atorvastatin, and apixaban. About 96 healthy adults will take part to see how these drugs interact in the body. The goal is to gather important safety information before testing JP-1366 in patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cha University Bundang Medical Center
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new drug alter the fate of common medications?
- Tiny study checks if two drugs clash in the body
- New drug combo aims to shrink hard-to-treat tumors
- New drug interaction study completed in 12 healthy volunteers
- Methotrexate drug interaction study aims to boost safety
- New antibiotic combo tested in healthy volunteers – no cure yet